April 19, 2014 7:10 AM ET


Company Overview of aTyr Pharma Inc.

Company Overview

aTyr Pharma Inc., a protein therapeutics company, engages in the discovery and development of biologic therapeutics based on physiocrines. It focuses on the discovery of phyisiocrines, which are a class of endogenous human proteins from amino acyl tRNA synthetases that function as extracellular signaling molecules in various physiologic settings; and the development of physiocrine-based medicines for indications in the areas of hematology, immune modulation, infection, and metabolism. The company’s lead product is Tmax, which is in preclinical development for thrombocytopenia. aTyr Pharma Inc. was incorporated in 2005 and is based in San Diego, California.

3565 General Atomics Court

Suite 103

San Diego, CA 92121

United States

Founded in 2005





Key Executives for aTyr Pharma Inc.

Executive Chairman and Chief Executive Officer
Age: 53
President and Chief Operating Officer
Founder and Director
Age: 72
Chief Medical Officer
Associate Director of Discovery Research
Compensation as of Fiscal Year 2013.

aTyr Pharma Inc. Key Developments

aTyr Pharma Appoints Biotech Pioneer, Dr. Ed Penhoet, to Board of Directors

aTyr Pharma (aTyr) announced the appointment of Ed Penhoet, Ph.D., to the company's board of directors (BOD). Dr. Penhoet, who co-founded Chiron, is an accomplished scientist and biotech pioneer. He has served on the Independent Citizens Oversight Committee (ICOC) for the California Institute of Regenerative Medicine (CIRM) and was recently appointed to President Obama's Council of Advisors on Science and Technology (PCAST). On aTyr's BOD, Dr. Penhoet will represent Alta Partners, an aTyr investor.

aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer

aTyr Pharma (aTyr) announced that David M. Weiner, M.D., joined aTyr as chief medical officer. Dr. Weiner most recently served as the chief medical officer and interim chief executive officer of Proteostasis Therapeutics in Boston.

aTyr Pharma Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 03:30 PM

aTyr Pharma Inc. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 03:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: John D. Mendlein, Executive Chairman and Chief Executive Officer.

Similar Private Companies By Industry

Company Name Region
BioAvenge United States
LifeStem, Inc. United States
Ciphergen Technologies, Inc. United States
Laser Pharma Inc. United States
Verax Biomedical, Incorporated United States

Recent Private Companies Transactions

Private Placement
July 29, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact aTyr Pharma Inc., please visit www.atyrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.